• 

  June 4, 2025

  Vivodyne Raises $40M to Scale AI and Robotics-Driven Human Tissue Platform for Drug Discovery

  William Ernst

• 

  May 6, 2025

  VivoSim Labs Introduces NAMkind Platform for Human-Based Drug Testing Models

  R.D. Solorzano

• 

  April 27, 2025

  Organovo Rebrands as VivoSim Labs to Advance 3D Bioprinting Technology

  R.D. Solorzano

• 

  April 3, 2025

  Organovo Sells FXR Drug Program to Eli Lilly in Strategic Deal to Advance IBD Therapies

  R.D. Solorzano

• 

  March 18, 2025

  CollPlant Biotechnologies Update – Reports Q3 2024 Results, Advances Regenerative Breast Implant Program

  R.D. Solorzano

• 

  March 18, 2025

  Vericel – Poised for Growth with Expanding Indications and Strong Margins

  R.D. Solorzano

• 

  March 7, 2025

  Sernova Biotherapeutics Secures FDA Clearance for Thyroid Cell Pouch IND Application

  R.D. Solorzano

• 

  March 6, 2025

  Trestle Bio Announces Research Collaboration with Humacyte

  R.D. Solorzano

• 

  February 26, 2025

  Xenotransplantation Advances: United Therapuetics and eGensis Companies to Watch

  R.D. Solorzano

• 

  February 18, 2025

  ARMI BioFabUSA A Catalyst for Regenerative Medicine

  R.D. Solorzano